AbbVie North Chicago Advanced Manufacturing Expansion

United States

Deal value: $850,000,000

AbbVie announced an $850 million expansion of its North Chicago manufacturing campus, adding advanced cleanroom and fill-finish capabilities for biologics.

AbbVie's $850 million North Chicago advanced manufacturing expansion is driven by the need to strengthen domestic production of biologics, immunology, oncology, and neuroscience medicines. The investment reflects a strategic response to anticipated volume growth, supply chain resilience, and policy shifts favoring U.S.-based pharmaceutical manufacturing. The core belief is that advanced, localized capacity will support innovation, regulatory compliance, and future medical breakthroughs.